Abstract | PURPOSE: METHODS: RESULTS: After 12 weeks, carteolol 1% reduced the mean +/- SE intraocular pressure from 25.0 +/- 0.3 to 19.5 +/- 0.3 mm Hg; timolol maleate 0.5% reduced the mean intraocular pressure from 25.2 +/- 0.3 to 19.6 +/- 0.3 mm Hg. The mean difference in trough intraocular pressure between carteolol and timolol maleate of -0.14 mm Hg was not significantly (P = .745) different (95% confidence limits, -0.97 to 0.70 mm Hg). Trough pulse and blood pressure also showed no consistent statistically significant differences between groups. The 2-hour postdose pulse, however, demonstrated a greater decrease in the timolol maleate than in the carteolol group (P < .001). Systemic and ocular signs and symptoms were similar between the groups except that the number of treatment-emergent reports of bradycardia was greater in the timolol maleate group (P = .039), and the carteolol group reported fewer ocular symptoms than the timolol maleate group did (P < .01). CONCLUSIONS:
|
Authors | W C Stewart, J S Cohen, P A Netland, H Weiss, L L Nussbaum |
Journal | American journal of ophthalmology
(Am J Ophthalmol)
Vol. 124
Issue 4
Pg. 498-505
(Oct 1997)
ISSN: 0002-9394 [Print] United States |
PMID | 9323940
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Antagonists
- Timolol
- Carteolol
|
Topics |
- Adolescent
- Adrenergic beta-Antagonists
(adverse effects, therapeutic use)
- Adult
- Aged
- Aged, 80 and over
- Carteolol
(adverse effects, therapeutic use)
- Double-Blind Method
- Female
- Humans
- Intraocular Pressure
(drug effects)
- Male
- Middle Aged
- Ocular Hypertension
(drug therapy, physiopathology)
- Timolol
(adverse effects, therapeutic use)
- Treatment Outcome
|